0001104659-22-069342.txt : 20220608 0001104659-22-069342.hdr.sgml : 20220608 20220608163528 ACCESSION NUMBER: 0001104659-22-069342 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220606 FILED AS OF DATE: 20220608 DATE AS OF CHANGE: 20220608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PIERCE GLENN CENTRAL INDEX KEY: 0001256964 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37625 FILM NUMBER: 221003922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Voyager Therapeutics, Inc. CENTRAL INDEX KEY: 0001640266 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-5340 MAIL ADDRESS: STREET 1: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 tm2218013-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-06 0 0001640266 Voyager Therapeutics, Inc. VYGR 0001256964 PIERCE GLENN C/O VOYAGER THERAPEUTICS, INC., 64 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 5.27 2022-06-06 4 A 0 22000 0 A 2032-06-06 Common Stock 22000 22000 D This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director. /s/ Robert Hesslein, as Attorney-in-Fact for Glenn Pierce 2022-06-08